Search research articles
Contact Us
Filters
Showing results (101-110 of 333) with videos related to
Page
of 34
Sort By:
British Journal of Cancer
|
October 31, 2013
Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC)
C Seidel, J Busch, S Weikert, et al.
Anti-Cancer Drugs
|
May 2, 2002
Capecitabine in patients with breast cancer relapsing after high-dose chemotherapy plus autologous peripheral stem cell transplantation--a phase II study
A Jakob, C Bokemeyer, S Knop, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1996
Paclitaxel-induced radiation recall dermatitis
C Bokemeyer, C Lampe, M Heneka, et al.
Investigational New Drugs
|
January 1, 1997
Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer cell lines
T A Dunn, H J Schmoll, V Grünwald, et al.
World Journal of Urology
|
November 7, 1999
Future prospects in the chemotherapy of metastatic nonseminomatous testicular germ-cell cancer
J T Hartmann, M A Kuczyk, C Kollmannsberger, et al.
Journal of the National Cancer Institute
|
January 4, 1995
Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer
C Bokemeyer, H J Schmoll, M A Kuczyk, et al.
Oncology Reports
|
May 20, 2011
Malignant fibrous histiocytoma of bone - Review of thirteen cases
J Hartmann, I Thiel, H Schmoll, et al.
Oncology Reports
|
May 21, 2011
Antitumor-activity and toxicity of continuous-infusion versus bolus administration of bleomycin in 2 heterotransplanted human testicular cancer cell-lines
C Bokemeyer, E Ludwig, D Reile, et al.
Oncology
|
January 1, 1996
Evaluation of late nephrotoxicity in long-term survivors of Hodgkin's disease
L M Fels, C Bokemeyer, J van Rhee, et al.
International Journal of Cancer
|
February 1, 1994
Modulation of cytostatic drugs by nifedipine in two heterotransplanted human testicular-cancer cell lines differing in their sensitivity to standard agents
C Bokemeyer, T Dunn, A Harstrick, et al.
Page
of 34
Search research articles
Search
Showing results (101-110 of 333) with videos related to
Sort By:
Page
of 34
British Journal of Cancer
|
October 31, 2013
Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC)
C Seidel, J Busch, S Weikert, et al.
Anti-Cancer Drugs
|
May 2, 2002
Capecitabine in patients with breast cancer relapsing after high-dose chemotherapy plus autologous peripheral stem cell transplantation--a phase II study
A Jakob, C Bokemeyer, S Knop, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1996
Paclitaxel-induced radiation recall dermatitis
C Bokemeyer, C Lampe, M Heneka, et al.
Investigational New Drugs
|
January 1, 1997
Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer cell lines
T A Dunn, H J Schmoll, V Grünwald, et al.
World Journal of Urology
|
November 7, 1999
Future prospects in the chemotherapy of metastatic nonseminomatous testicular germ-cell cancer
J T Hartmann, M A Kuczyk, C Kollmannsberger, et al.
Journal of the National Cancer Institute
|
January 4, 1995
Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer
C Bokemeyer, H J Schmoll, M A Kuczyk, et al.
Oncology Reports
|
May 20, 2011
Malignant fibrous histiocytoma of bone - Review of thirteen cases
J Hartmann, I Thiel, H Schmoll, et al.
Oncology Reports
|
May 21, 2011
Antitumor-activity and toxicity of continuous-infusion versus bolus administration of bleomycin in 2 heterotransplanted human testicular cancer cell-lines
C Bokemeyer, E Ludwig, D Reile, et al.
Oncology
|
January 1, 1996
Evaluation of late nephrotoxicity in long-term survivors of Hodgkin's disease
L M Fels, C Bokemeyer, J van Rhee, et al.
International Journal of Cancer
|
February 1, 1994
Modulation of cytostatic drugs by nifedipine in two heterotransplanted human testicular-cancer cell lines differing in their sensitivity to standard agents
C Bokemeyer, T Dunn, A Harstrick, et al.
Page
of 34